For animal treatment only.

Do not exceed the recommended dosage.

RONAXAN should not be used in pregnant animals.

Do not use in known cases of hypersensitivity to the active ingredient.

Vomiting, oesophagitis and oesophageal ulcerations have been reported as side effects following doxycycline therapy and RONAXAN should not therefore be administered to patients with dysphagia, or diseases accompanied by vomiting.

Photodermatitis has occurred following tetracycline therapy after exposure to intense sun or ultraviolet light.

The use of tetracycline during tooth development may lead to tooth discoloration. Doxycycline, because of the lower affinity for calcium, carries a lower risk than other tetracyclines.

Cross resistance to other tetracyclines can occur.

Doxycycline should not be used concurrently with other antibiotics especially bactericidal drugs such as the β-lactams.

Wash hands thoroughly after use.

Handle the tablets with care if you know you are hypersensitive (allergic) to tetracycline. In case of accidental ingestion, seek medical advice.

Any unused product or waste material should be disposed of in accordance with national requirements.